Suchergebnisse - "Yang, Jin-Ji"

PubPharm (239)

1

Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION

enthalten in: British journal of cancer | 2024

von Kato, T. | Yang, J. | Ahn, M. | +14

2

Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer

enthalten in: Journal of translational medicine | 2024

von Luo, W. | Mei, S. | Huang, Z. | +19

3

Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer

enthalten in: Journal of translational medicine | 2024

von Luo, W. | Mei, S. | Huang, Z. | +19

4

Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lu, C. | Wei, X. | Wang, Z. | +23

5

PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901) : A phase 2, randomized, controlled trial

enthalten in: Science bulletin | 2024

von Maggie Liu, S. | Huang, J. | Deng, J. | +18

6

Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma

enthalten in: Oncoimmunology | 2024

von Wei, X. | Lu, C. | Zhang, Y. | +17

7

Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients : a comparative real-world study

enthalten in: Therapeutic advances in medical oncology | 2024

von Su, J. | Weng, C. | Lin, X. | +10

8

Molecular features and clinical outcomes of EGFR-mutated, MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy

enthalten in: Therapeutic advances in medical oncology | 2024

von Fang, M. | Cheng, J. | Chen, Y. | +5

9

Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804) : a multicenter open-label phase II study

enthalten in: Signal transduction and targeted therapy | 2023

von Liu, S. | Dong, S. | Yang, X. | +19

10

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8) : a multi-center, single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2023

von Maggie Liu, S. | Dong, X. | Wang, Z. | +23

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]